News | Stents Drug Eluting

October 1, 2018 — Recent results from the BIONYX randomized clinical study showed the novel, thin-strutted, polymer ...

Home October 01, 2018
Home
Technology | Stents Drug Eluting

Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its Premarket Approval (PMA) application to market the Eluvia Drug-Eluting Vascular Stent System, specifically developed for the treatment of peripheral artery disease (PAD). The Eluvia stent utilizes a drug-polymer combination to offer sustained release of the drug paclitaxel for a one-year timeframe, designed to prevent tissue regrowth that might otherwise block the stented artery.

Home October 01, 2018
Home
Two of the top videos in September both had to do with interventional cardiology hemodynamic support support protocols. The top piece of content in September is an interview on the protocols used to determine what device technology to use at Henry Ford Hospital in Detroit. Number 13 on the list is another video on late-breaking data presented TCT 2018 from the National Cardiogenic Shock Initiative (NCSI) where mortality was improved by 50 percent over the current standard of care. Pictured here are Abiomed
Feature | Dave Fornell, Editor

October 1, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home October 01, 2018
Home
News | Stents Bioresorbable

New results from the RENASCENT studies presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference showed Amaranth Medical’s Magnitude sirolimus-eluting bioresorbable scaffold (BRS) continued to perform well clinically at nine months.

Home October 01, 2018
Home
Videos | Hemodynamic Support Devices

Nevin Kapur, M.D., FAHA, FACC, FSCAI, executive director, Cardiovascular Center for Research and Innovation, Tufts ...

Home October 01, 2018
Home
News | Heart Failure

Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical trial showed a statistically significant reduction in regurgitant volume at one year compared to the control cohort receiving guideline-directed medical therapy. Results of the REDUCE FMR trial were presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego.

Home September 28, 2018
Home
News | Ultrasound Imaging

Clarius Mobile Health is introducing the Clarius Cart at the American College of Emergency Physicians (ACEP) 2018 Scientific Assembly, Oct. 1-4 in San Diego. The Clarius Cart is an ultrasound accessory to complement the company’s lineup of wireless ultrasound scanners for use in more traditional settings. It is a mobile cart with a lockable cabinet to hold scanners, a working space for procedures, and a charging dock for scanner batteries and smart devices. It is designed for hospital and clinical environments to give clinicians the flexibility of personal ultrasound with the utility of traditional cart-based systems, without any cables.

Home September 28, 2018
Home
News | Heart Valve Technology

September 28, 2018 — At one year following transcatheter aortic valve replacement (TAVR), implantation with the Portico ...

Home September 28, 2018
Home
News | Artificial Intelligence

September 28, 2018 — Artificial intelligence (AI) driven by machine learning (ML) algorithms is a branch in the field of ...

Home September 28, 2018
Home
News | Heart Valve Technology

The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (TAVR) in patients with intermediate to high surgical risk found local anesthesia to be both safe and effective. In addition, the study found that a current generation balloon-expandable valve had similar outcomes to a current generation self-expanding one.

Home September 28, 2018
Home
Videos | Hemostasis Management

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...

Home September 27, 2018
Home
Technology | Stents

September 27, 2018 — Biotronik recently announced U.S. Food and Drug Administration (FDA) approval of the PK Papyrus ...

Home September 27, 2018
Home
Videos | Artificial Intelligence

Rami Doukky, M.D., professor of medicine, preventative medicine and radiology, and chief of the Division of Cardiology ...

Home September 27, 2018
Home
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.
Sponsored Content | Feature | ECG

Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the ...

Home September 27, 2018
Home
News | Nuclear Imaging

Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of gamma cameras. Further, the numerous developments in radionucleotides are anticipated to favor the adoption of solid state cameras and mobile gamma cameras. These findings are presented in a new research study on the global mobile gamma cameras market by Future Market Insights (FMI).

Home September 27, 2018
Home
Subscribe Now